Press Releases
Technologies and tactics for accelerating end-to-end biologic drug development
MEDIA FOCUS
Technologies and tactics for accelerating end-to-end biologic drug development
Seahee Kim Samsung Biologics provides insight into how contract development and manufacturing organizatons(CDMOs) are applying new and effective methodologies to accelerate molecules to market.
Creating new biologic drugs from early research is a complex process, but certain development methodologies and practices are proving to reach clinical and commercial goals faster.
All rights are reserved by the media that published this article.
Creating new biologic drugs from early research is a complex process, but certain development methodologies and practices are proving to reach clinical and commercial goals faster.
All rights are reserved by the media that published this article.